A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

Share

Email PageEmail Print PagePrint

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Enfermedad renal terminal - Treatment

Nombres alternativos

Insuficiencia renal terminal; Insuficiencia renal en estado terminal; Nefropatía terminal

Tratamiento:

Los únicos tratamientos para la enfermedad renal terminal son la diálisis o el trasplante de riñón.

Usted debe empezar a prepararse para la diálisis antes de que sea absolutamente necesario. La preparación incluye aprender acerca de la diálisis y los tipos de terapias con ésta, al igual que la colocación de un acceso para dicha diálisis.

Ver también:

El tratamiento generalmente incluye un IECA, un bloqueador de los receptores de angiotensina u otros medicamentos para la hipertensión arterial.

Tal vez necesite hacer algunos cambios en su dieta:

  • Consumir una dieta baja en proteínas
  • Obtener suficientes calorías si está bajando de peso
  • Limitar los líquidos
  • Limitar la sal, el potasio, el fósforo y otros electrolitos

Ver: dieta y enfermedad renal crónica para mayores detalles.

Otros tratamientos pueden abarcar:

  • Calcio y vitamina D extra (siempre hable con el médico antes de tomarlos)
  • Medicamentos especiales llamados enlaces de fosfato, para ayudar a evitar que los niveles de fósforo se vuelvan demasiado altos
  • Tratamiento para la anemia, como hierro extra en la alimentación, comprimidos de hierro, inyecciones especiales de un medicamento llamado eritropoyetina y transfusiones de sangre

Hay diferentes tratamientos disponibles para los problemas con el sueño o el síndrome de la pierna inquieta.

Los pacientes con enfermedad renal crónica deben mantener al día las vacunas importantes, como:

Grupos de apoyo:

Para buscar recursos adicionales, ver el artículo grupos de apoyo para la enfermedad renal.

Pronóstico:

Sin diálisis o un trasplante de riñón, la muerte se presentará por la acumulación de líquidos y productos de desecho en el organismo. Ambos tratamientos pueden tener riesgos y consecuencias graves. El pronóstico es diferente para cada persona.

Posibles complicaciones:

  • Reviewed last on: 8/31/2010
  • Charles Silberberg, DO, Private Practice specializing in Nephrology, Affiliated with New York Medical College, Division of Nephrology, Valhalla, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Referencias

Tolkoff-Rubin N. Treatment of irreversible renal failure. In: Goldman L, Ausiello D, eds. Goldman: Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 133.

Mitch WE. Chronic kidney disease. In: Goldman L, Ausiello D, eds. Goldman: Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 131.

KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530.

KDOQI: National Kidney Foundation. II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. 2006;47(5 Suppl 3):S16-S85.

Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 Suppl 1):S1-S290.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010;153:23-33.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Adam QualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Connect with UMMC
Facebook Twitter YouTube Blog iPhone

Please rate the quality of this article.

Do you find this article to be helpful / informative?
              
Poor                                       Excellent

Do you have any brief comments on this page: (up to 255 characters)

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885